Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Van Wijnendaele

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Developments in Biological Standardization|January 1, 1985
Production in yeast of hepatitis B surface antigen by R-DNA technologyM De Wilde, T Cabezon, N Harford, et al.
Postgraduate Medical Journal|January 1, 1987
Development of a hepatitis B vaccine from transformed yeast cellsJ Pêtre, F Van Wijnendaele, B De Neys, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1989
Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120C Thiriart, M Francotte, J Cohen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Developments in Biological Standardization|January 1, 1985
Production in yeast of hepatitis B surface antigen by R-DNA technologyM De Wilde, T Cabezon, N Harford, et al.
Postgraduate Medical Journal|January 1, 1987
Development of a hepatitis B vaccine from transformed yeast cellsJ Pêtre, F Van Wijnendaele, B De Neys, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1989
Several antigenic determinants exposed on the gp120 moiety of HIV-1 gp160 are hidden on the mature gp120C Thiriart, M Francotte, J Cohen, et al.
Pageof 1